Retrospective Review of Factors Associated with Survival in Patients Treated with Gamma Knife for Recurrent Glioblastoma.

被引：0
|
作者：
Mikucki, M. [1 ]
Hermann, G. M. [1 ]
Prasad, D. [1 ]
机构：
[1] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.2300
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2234
引用
收藏
页码：E104 / E104
页数：1
相关论文
共 50 条
  • [21] Gamma Knife Surgery versus Reoperation for Recurrent Glioblastoma Multiforme
    Skeie, Bente Sandvei
    Enger, Per Oyvind
    Brogger, Jan
    Ganz, Jeremy Christopher
    Thorsen, Frits
    Heggdal, Jan Ingeman
    Pedersen, Paal-Henning
    WORLD NEUROSURGERY, 2012, 78 (06) : 658 - 669
  • [22] Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab
    Prados, Michael
    Cloughesy, Timothy
    Samant, Meghna
    Fang, Liang
    Wen, Patrick Y.
    Mikkelsen, Tom
    Schiff, David
    Abrey, Lauren E.
    Yung, W. K. Alfred
    Paleologos, Nina
    Nicholas, Martin K.
    Jensen, Randy
    Vredenburgh, James
    Das, Asha
    Friedman, Henry S.
    NEURO-ONCOLOGY, 2011, 13 (01) : 143 - 151
  • [23] Gamma Knife Stereotactic Radiosurgery in Combination with Bevacizumab for Recurrent Glioblastoma
    Morris, Saint-Aaron L.
    Zhu, Ping
    Rao, Mayank
    Martir, Magda
    Zhu, Jay J.
    Hsu, Sigmund
    Ballester, Leomar Y.
    Day, Arthur L.
    Tandon, Nitin
    Kim, Dong H.
    Shepard, Scott
    Blanco, Angel
    Esquenazi, Yoshua
    WORLD NEUROSURGERY, 2019, 127 : E523 - E533
  • [24] GAMMA-KNIFE RADIOSURGERY FOR RECURRENT GLIOBLASTOMA RESISTANCE TO THE TEMOZOMOLIDE
    Satou, K.
    NEURO-ONCOLOGY, 2010, 12 : 41 - 41
  • [25] Risk factors associated with the survival of endodontically treated teeth A retrospective chart review
    Chang, Yucheng
    Choi, Minyoung
    Wang, Yu-Bo
    Lee, Su-Min
    Yang, Min
    Wu, Brian H.
    Fiorellini, Joseph
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2024, 155 (01): : 39 - 47
  • [26] Single-institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice
    Desjardins, Annick
    Herndon, James E., II
    McSherry, Frances
    Ravelo, Arliene
    Lipp, Eric S.
    Healy, Patrick
    Peters, Katherine B.
    Sampson, John H.
    Randazzo, Dina
    Sommer, Nicolas
    Friedman, Allan H.
    Friedman, Henry S.
    HEALTH SCIENCE REPORTS, 2019, 2 (04)
  • [27] Analysis of long-term survival in patients with glioblastoma.
    Melegari, Elisabetta
    Dall'Agata, Monia
    Guiducci, Graziano
    Cremonini, Anna Maria
    Cerasoli, Serenella
    Ibrahim, Toni
    Sintini, Michele
    Cenni, Patrizia
    Bomprezzi, Chiara
    Faedi, Marina
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] Clinical and molecular features associated with long-term survival of elderly patients with glioblastoma.
    Weller, Michael
    Sill, Martin
    Hentschel, Bettina
    Felsberg, Joerg
    Jones, David T. W.
    Gramatzki, Dorothee
    Kaulich, Kerstin
    Happold, Caroline
    Tonn, Joerg
    Herrlinger, Ulrich
    Schackert, Gabriele
    Westphal, Manfred
    Capper, David
    Kumar, Rajiv
    Hemminki, Kari
    Pietsch, Torsten
    Loeffler, Markus
    Pfister, Stefan M.
    von Deimling, Andreas
    Reifenberger, Guido
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] Baseline cognitive function to predict survival in patients with glioblastoma.
    Peters, Katherine B.
    Woodring, Sarah
    Healy, Patrick
    Herndon, James Emmett
    Lipp, Eric S.
    Minchew, Janet
    Ben Zalutsky
    Affronti, Mary
    Randazzo, Dina
    Desjardins, Annick
    Vlahovic, Gordana
    Friedman, Henry S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [30] Efficacy and safety study of fotemustine and bevacizumab in patients with recurrent glioblastoma.
    Escudero, Laura Sanchez
    Urbano, Maria Amor
    Garces, Maria Yeray Rodriguez
    Murillo, Fatima Toscano
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345